Since 1992, Cambridge Healthtech Institute (CHI) has brought together the life science community to advance development of small molecule drugs, biologics and other therapeutic modalities. In the challenging environment of social distancing and quarantine, CHI, in the format of a series of interactive webinars, once again takes the leadership role of connecting the life science community by bringing you the latest research and technologies for new drug discovery and development.